Epstein-Barr Virus Capsid Antigen BFRF3 Recombinant
$800.00 – $1,100.00
| accession | P14348 |
| Source | DNA sequence encoding immunodominant fragment of Epstein-Barr ViruscapsidBFRF3 protein expressed in Escherichia Coli. |
| Molecular weight | Recombinant EBV p18 encodes the immunodominant sequences of theEpstein-Barr Viruscapsid p18protein.This molecule has a calculated mass of approximately 13kDa. Recombinant EBV p18 contains an N terminal GST purification tag and migrates as an approximately 39 kDa protein under non-reducing conditions and reducing conditions in SDS-PAGE. |
| Purity | >95%, as determined by SDS-PAGE. |
| Applications | Recombinant human EBV p18 antigen is suitable for ELISA and Western blots, excellent antigen for detection of EBV with minimal specificity problems. |
| Presentation | Lyophilized from 25mM Tris-Hcl pH 7.2, 1mM EDTA and 50% glycerol. |
| Reconstitution | A quick spin of the vial followed by reconstitution in distilled water to a concentration not less than 0.1 mg/mL. This solution can then be diluted into other buffers. |
| Storage | The lyophilized protein is stable for at least 2 years from date of receipt at -20° C. Upon reconstitution, this protein can be stored in working aliquots at 2° - 8° C for one month, or at -20° C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles. |
| Usage | This product is for research purposes only.It may not be used for therapeutics or diagnostic purposes. |